Maritza Perez, MD
Dermatology · New Canaan, CTNPI 1831140730
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $21,738 of the $25,945 with a category attached, or 83.8%. Regeneron Healthcare Solutions, Inc. accounts for 71.6% of it on its own, with 29 other manufacturers making up the rest. Reporting peaked in 2024 at $13,707 and has fallen 76.8% since, to $3,178 in 2025.
Across 116 payments — averaging $223.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$19K
- AbbVie$3K
- Galderma Laboratories, L.p.$1K
- Merz North America, Inc.$632
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$366
- Novartis$268
- plus $1K from 24 others
What the payments were for
- Consulting fees$21,73884%
- Travel & lodging$7863%
- Food & beverage$3,35213%
- Education$690%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 26 | $18,581 |
| AbbVie(2 entities) | 8 | $3,204 |
| Galderma Laboratories, L.p. | 4 | $1,403 |
| Merz North America, Inc. | 8 | $632 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 4 | $366 |
| Novartis | 6 | $268 |
| GSK | 6 | $170 |
| Janssen Scientific Affairs, LLC | 2 | $141 |
| VYNE Pharmaceuticals Inc. | 7 | $136 |
| Journey Medical Corporation | 3 | $125 |
| Pfizer | 4 | $117 |
| Sanofi | 4 | $107 |
| Mayne Pharma Commercial LLC | 5 | $103 |
| Lilly USA, LLC | 2 | $85 |
| LEO Pharma Inc. | 4 | $69 |
| Genentech USA, Inc. | 3 | $68 |
| Paratek Pharmaceuticals, Inc. | 3 | $59 |
| Sanofi Pasteur Inc. | 2 | $46 |
| Johnson & Johnson | 1 | $42 |
| UCB, Inc. | 1 | $34 |
| Nabriva Therapeutics, PLC | 2 | $32 |
| Melinta Therapeutics, LLC | 2 | $26 |
| EPI Health, LLC | 1 | $21 |
| Merck | 1 | $18 |
| Sun Pharmaceutical Industries Inc. | 1 | $18 |
| Organogenesis Inc. | 1 | $18 |
| Almirall LLC | 1 | $17 |
| Encore Dermatology Inc. | 1 | $15 |
| Strata Skin Sciences, Inc. | 2 | $13 |
| Sebela Pharmaceuticals Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$25,945 in reported general payments places this provider in the 85th percentile of 222 dermatology providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gentamicin Sulfate | 34 | $755 |
| Mupirocin | 45 | $303 |
| Cephalexin | 24 | $33 |
Paid to pharmacies, not to this prescriber.
Other dermatology in New Canaan
- Ellen de MollNew Canaan$103K
- Michael PayetteCromwell$3.2M
- Bruce StroberCromwell$2.9M
- Brett KingFairfield$2.5M
- Mona ShahriariCromwell$2.2M
- Jeremy MossMadison$2M
- Brittany CraiglowFairfield$1.9M
- Meagen McCuskerEnfield$1.8M
- Marcus McFerrenOrange$872K
- Christopher BunickNew Haven$661K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.